Home
  Go 
Advanced SearchTopics Login Become a Member 

Locate A Chapter

HFMA News - Wednesday, September 03, 2008

HFMA NEWS


Wednesday, September 03, 2008
MetLife Decision May Lead to More Approved Employee Health Benefit Claims--and More Litigation Over Denied Claims, Says Legal Scholar

A recent Supreme Court decision will likely lead to more approvals of health insurance claims submitted by employees and more litigation over those claims that are denied, a legal scholar concludes in a Health Affairs web exclusive published today.

In its June 2008 decision Metropolitan Life Insurance (MetLife) v. Glenn, the Supreme Court recognized the conflict of interest that often faces plan administrators of the Employee Retirement Income Security Act (ERISA): Under ERISA, the plan administrator often both evaluates the claims made by employees and pays the claims it decides to approve. In MetLife, the Supreme Court made it easier for this conflict to be invoked in court by employees who sue the plan administrator to reverse denied claims. The case involved the denial of a disability claim by MetLife, the plan administrator for the disability benefits ERISA plan offered to Sears employees, but the rules announced by the court in its opinion apply to lawsuits over denials of claims for health benefits as well.

The MetLife decision “clarifies issues that have divided the lower federal courts,” writes Tim Jost, the Robert Willet Family Professor in the Washington and Lee University School of Law. “Insured and self-insured ERISA plans are indeed conflicted, and although their determinations are not to be retried by the federal courts [from scratch], the lower courts should not uphold determinations simply because they are not ‘off the wall.’” Read the abstract.

posted on 9/3/2008 7:52:47 AM (CST)  Permalink   
Whistle-Blower Lawsuits Helped Recover at Least $9.3 Billion from Healthcare Providers, Analysis Finds

Whistle-blowers have helped the Department of Justice (DOJ) recover at least $9.3 billion from healthcare providers and pharmaceutical companies that allegedly defrauded states and the federal government, according to a report published in the Sept. 2 issue of Annals of Internal Medicine.

DOJ in the 1990s began to use whistle-blowers in efforts to fight healthcare fraud, and whistle-blowers currently initiate 90 percent of such cases for the department. For the report, the researchers reviewed DOJ records from 379 healthcare fraud cases between 1996 and 2005, although they had information for only three-fourths of those cases. According to the report, the number of healthcare fraud cases has decreased in recent years, but the amount that DOJ recovered in those cases increased.

The researchers cited the need to conduct additional research on whistle-blower lawsuits to determine which types of cases are more likely to lead to recoveries to allow DOJ to expedite such cases. Read the abstract.

posted on 9/3/2008 7:51:12 AM (CST)  Permalink